We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · July 28, 2021

Sunitinib Is Noninferior to Sunitinib/Nephrectomy in Metastatic RCC

European Urology


Additional Info

Disclosure statements are available on the authors' profiles:

European Urology
Sunitinib Alone or After Nephrectomy for Patients With Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?
Eur Urol 2021 Jun 26;[EPub Ahead of Print], A Méjean, A Ravaud, S Thezenas, C Chevreau, K Bensalah, L Geoffrois, A Thiery-Vuillemin, L Cormier, H Lang, L Guy, G Gravis, F Rolland, C Linassier, E Lechevallier, S Oudard, B Laguerre, M Gross-Goupil, JC Bernhard, S Colas, L Albiges, T Lebret, JM Treluyer, MO Timsit, B Escudier

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading